- -
- 100%
- +
Furthermore, I want this book to be completely accessible to anyone, not just patients and their doctors. Before diving into the deep end, here is a quick, unvarnished dictionary of terms that will keep popping up. These definitions match what you’ll find in medical textbooks and pharmaceutical brochures, even if the reality is vastly different.
Multiple sclerosis — A chronic autoimmune condition triggered by a systematic malfunction in the body's defenses. Even though lymphocytes act as the primary saboteurs in the pathogenesis, the medical establishment classifies it as a brain disorder, leaving it firmly in the hands of neurologists.
Neuron — A brain cell responsible for transmitting electrical impulses. The human brain houses roughly 86 billion of them; the spinal cord holds about 13 to 14 million.
Axon — The long projection of a neuron that functions exactly like an electrical wire, linking one neuron to another. To ensure the electrical impulse reaches its destination without short-circuiting, the axon requires insulation.
Myelin — The insulation wrapping the axon. In the central nervous system, this protective winding is produced by specialized cells called oligodendrocytes. Specifically, myelin is an extension of the oligodendrocyte’s own cell membrane. A single oligodendrocyte wraps its insulation around dozens of different axons.
Demyelination lesion (Hotspot) — A localized area in the central nervous system where immune cells strip the insulation off the wires. On a contrast-enhanced MRI, "active" hotspots flare up as bright, burning white dots.
Relapse — The sudden worsening of old symptoms or the appearance of entirely new ones, lasting at least 24 hours. Relapses are traditionally tied to the appearance of those burning dots on the scan, which doctors interpret as active demyelination.
Pulse therapy — A high-dose blitz of intravenous corticosteroids. Both doctors and patients operate under the assumption that a steroid pulse can "extinguish" a relapse and put the disease back to sleep, ushering in a remission.
Remission — The phase where multiple sclerosis is allegedly dormant. It is defined by flatlining disability scores, an absence of new symptoms, and a quiet MRI scan. The entire system is built on the myth that MS neatly alternates between active relapses and quiet remissions.
EDSS — A crude, step-based scale used by neurologists to measure a patient’s level of physical disability. It serves as the primary metric for proving whether a Disease-Modifying Therapy (DMT) is effective.
DMTs (Disease-Modifying Therapies) — The global arsenal of drugs marketed for MS. The dominant narrative promises that the "right" DMT will lock the disease in perpetual remission and shield you from future attacks.
CSF (Cerebrospinal fluid) — The specialized fluid that cushions the brain and spinal cord. In a healthy body, it contains almost zero blood cells due to the heavy security of the central nervous system's protective barriers.
Blood-brain barrier (BBB) — The ultimate security system separating the bloodstream from the delicate tissues of the brain. It isn't a single physical wall; it exists at every microscopic point where a blood vessel meets brain tissue.
Intrathecal — Anything occurring deep within the brain tissue, completely behind the blood-brain barrier. Intrathecal MS processes are intensely clonal.
Lymphocyte — A white blood cell and the absolute backbone of the adaptive immune system. A lymphocyte wakes up and goes to war the moment it encounters a protein fragment that snaps perfectly into its receptor.
Epitope — The microscopic section of a molecule that a lymphocyte’s receptor actually locks onto. It’s usually just a sequence of 5 to 25 amino acids—essentially, a tiny cluster of LEGO bricks.
Clonal expansion — The rapid replication of an activated lymphocyte. A single rogue cell can divide repeatedly, creating a massive, identical army of tens of thousands of copies—clones.
Patient Story: Marina Solovyova, 52
I want you to meet Marina. Her trajectory heavily shaped the core thesis of this book. To be clear: Marina is a real person, and you’ll find her actual contact info at the end of her story. She understands exactly how vital her experience might be for you, and she knows firsthand how anchoring your identity to an ambiguous diagnosis can derail your entire life. Pay close attention to this detail: if your diagnosis was handed to you based entirely on an MRI scan while your spinal tap came back completely clear, your condition looks a lot less like multiple sclerosis than Marina's did.
Her story exposes a fundamental truth about human nature: if you cannot independently evaluate technical data, your opinion isn't formed by facts—it is dictated entirely by the authority of the person delivering them. If you finish this book and still believe interferons actually do something, ask yourself: is that belief grounded in a hard understanding of human biology, or are you just bowing to the prestige of the doctor who wrote the prescription? And does a doctor’s prestige ever guarantee that their advice is actually right?
The authority of a certified neurologist and top-tier specialist at a prestigious Institute of Neurology was the exact reason I didn't pack my bags and sprint to the Pirogov Hospital the day I was diagnosed. The authority of two more high-ranking MS specialists at the Moscow MS Center convinced me they knew best, and a shallow surf through online forums seemed to back them up. How could I have guessed they were all completely wrong? Three elite specialists with advanced degrees?
As it turns out, my own diagnostic nightmare wasn't even the most extreme case, and my collection of expert opinions wasn't nearly as impressive as Marina's. Let me repeat: Marina is a real person, and she is fully prepared to verify everything below.
Multiple sclerosis gatecrashed my life much later than it does for most; I was 38 when I first crossed paths with the disease. Should that age gap have been a massive red flag? Absolutely. But hindsight is always 20/20. Let's look at how it actually unfolded.
It started with a rare biological fluke: I managed to avoid getting chickenpox as a child. When the virus finally caught up with me as an adult, it hit with a vengeance. That's the brutal nature of chickenpox—kids breeze through it, but adults get absolutely wrecked. I was profoundly sick, and even after the rash cleared, my body refused to bounce back. I would wake up completely drained, feeling as though I had been running a marathon all night. The exhaustion was so alien that I immediately started knocking on doctors' doors.
They poked and prodded, but found absolutely nothing. The physicians at the local clinic actually started hinting that I was playing hooky like a schoolchild, faking a mysterious illness just to score a sick leave. I had to explicitly explain to them that I was a corporate director, had zero need for sick leave, and was genuinely terrified because my body was failing.
To fix myself, I started bouncing between health resorts, diving into spiritual practices, trying every detox fad under the sun, and trying to patch up my collapsing health. Nothing worked. Time kept ticking, and I was slowly, methodically getting worse, then worse, and then a little worse still. The exhaustion became a permanent baseline, creeping in so smoothly that I barely noticed the shift. I just adapted to my own weakening body until, two years in, the floor completely dropped out.
The entire left side of my body suddenly went completely numb. My left arm and leg simply forgot how to belong to me. The acute numbness eventually receded, and I slowly regained control of my limbs, but as it lifted, a fresh wave of symptoms rushed in to take its place: a permanent, maddening hum in my head, profound weakness, and violent bouts of vertigo. It got to the point where I would be standing in polite, professional company and simply collapse to the floor from sheer dizziness.
Like most people, I tried to brush it off at first. I had a mountain of urgent corporate tasks, quarterly tax reports to file, documents that only I could sign, and a million other excuses. I was pushing myself through hell—so much so that outsiders couldn't ignore it anymore. It culminated when my driver, a man who had never broken protocol, turned around, yelled at me, and announced we were driving straight to the ER, flatly stating that my opinion on the matter was entirely irrelevant. He admitted later that he thought I was having a massive stroke and was terrified that we were burning precious minutes.
I panicked right along with him. We called an ambulance, and that was the moment I entered the diagnostic meat-grinder. The MRI of my brain revealed a constellation of hotspots, some measuring an incredible 2.7 centimeters. My scan looked like a brilliant starry night. Initially, they penciled in "multiple sclerosis" with a tentative question mark, but elite specialists at the Institute of Neurology quickly upgraded it to an absolute certainty. Definitive multiple sclerosis. No doubt, no alternatives.
My mental state back then was a living nightmare. I would walk into the kitchen and find myself completely incapable of making a cup of tea—my cognitive gears were grinding, and my ability to organize even the simplest task had completely evaporated. It was terrifying. I had to start barking internal orders at myself, narrating every microscopic action in my head like an adult managing a severely disabled child: "Pick up the mug. Put the tea bag in. Pour the boiling water."
To cap it all off, my partner dumped me right in the middle of this crisis—a move for which I would like to publicly thank him from the bottom of my heart. Actually, he isn't the only one who deserves my gratitude; I am paradoxically thankful to every single person who betrayed me and walked away back then. If it weren't for your abandonment, I never would have dug deep enough to claw my way out. And I was in a massive hole: I was losing my balance constantly, veering wildly to the side while walking, and crashing to the ground like a broken toy. I collected bruises from every wall and doorframe in my apartment, and one violent fall actually knocked my front tooth out. This living hell dragged on for a year, and then things got worse: they put me on a DMT.
First came Ronbetal, an interferon—a standard first-line therapy meant to shield me from the progression of my alleged sclerosis. The side effects were barbaric. My temperature would skyrocket to 39°C (102°F) every single evening. My entire body would ache so violently that I was practically rolling on the floor in agony. You don't endure that kind of torture for nothing; I convinced myself it was the price of admission for a wheelchair-free future. It never even occurred to me to research what this chemical actually was or how it functioned; besides, it was glaringly obvious that my neurologist didn't really understand it either.
Unable to cope with the relentless toxicity, I was eventually rotated onto Copaxone. I injected myself with glatiramer acetate every single day for five long years. Compared to the interferon nightmare, it felt like an upgrade, but it was far from benign: the injection sites hardened into painful, permanent lumps that drove me insane. Read that sentence again and let it sink in: I injected myself with Copaxone every single day for five years, and every single shot left a permanent, hardened knot under my skin.
After five years of needles, my doctor shifted me onto a new oral medication, Tecfidera. While swallowing a pill was infinitely more convenient than daily injections, it brought its own toxic baggage: my thyroid started failing, I was hit by sudden, violent hot flashes and night sweats, and there were days when the sheer, marrow-deep exhaustion made me question whether I wanted to keep existing at all. Everything was bleak, and the playbook dictated that it would only get bleaker—after all, I had multiple sclerosis, and that highway only runs in one direction. Focus on this timeline: by the summer of 2021, over eight years had passed since my initial diagnosis. For those eight years, neither I, nor my family, nor a single doctor ever doubted for a fraction of a second that I was a multiple sclerosis patient.
In August 2021, bordering on a total physical collapse, I forced my way into an inpatient bed at the Brain Institute. I underwent a fresh battery of advanced diagnostics, and then I took my charts to a legendary specialist in St. Petersburg—Dr. Lidia Nikolaevna Prakhova, a Doctor of Sciences with nearly three decades of neurological tenure. She reviewed my files, looked up, and delivered a calm, shattering verdict: I did not have multiple sclerosis, and I never did. Let me type that again so there is zero ambiguity: she flatly stated that I did not have the disease that a small army of medical experts had been aggressively medicating me for for eight and a half years. According to Dr. Prakhova, I had suffered a single, massive attack of ADEM (Acute Disseminated Encephalomyelitis)—hardly a walk in the park, but crucially, a one-time event, not a lifelong sentence. The condition, she explained, was notoriously erratic—it shows up, wreaks havoc, and vanishes entirely on its own schedule. All those years of interferons and copaxones had been completely useless.
To put this in perspective: over those eight years, my nonexistent multiple sclerosis was managed by some of the most famous, highly decorated neurologists in the country—names like Boyko, Bisaga, Khachanova, Davydovskaya, Ovcharov, and Pozhidaeva. I had sat in consulting rooms at the Brain Institute and the Institute of Neurology. Every single one of them was absolutely certain I had MS, and every single one of them was eager to pump me full of interferons and copaxones. In fact, they almost certainly convinced themselves that their prescriptions were the exact reason my disease wasn't progressing. To be completely honest, I believed it too, even if it feels surreal to look back on now.
Fortunately, my story has a genuine Hollywood happy ending. My health has rebounded dramatically, I fell deeply in love, and I got married. I have a gorgeous family, we are financially secure, and we spend our time traveling and living by the ocean for months on end. My doctors noted that a coastal, warm climate works wonders for my residual symptoms—and I am more than happy to oblige. We are happy, we live a lush, full life, and I never have to track the progression of my multiple sclerosis ever again.
What should we take away from all this? The list of conclusions is so long that I barely know where to begin. And is a book written by someone else even the right venue for my personal epilogue? Actually, it's perfect—this is my story, and nobody can distill its lessons better than me.
Should I have questioned the diagnosis fourteen years ago, realizing that while I felt young, I was technically way outside the prime demographic for an MS debut? Yes, I see that clearly now. Should I have blindly trusted a row of diplomas simply because they wore white coats and muttered the Hippocratic Oath? Absolutely not—that was a catastrophic mistake. Did I ever suspect, deep down, that I didn't have sclerosis at all, and that my doctors secretly suspected it too, finding it much easier to "manage" a perfectly healthy person with their interferons? More times than I have fingers and toes to count.
Do I mourn the lost years, the shattered nerves, the wasted money, and the unprompted damage to my body? Of course I do, but the past is a locked vault; nobody has ever managed to reverse time. Still, they say all's well that ends well, and my ending is magnificent—I have been living beautifully, entirely free of MS and pharmaceutical chemicals, for over five solid years. Consider this chilling detail: if I hadn't pushed like a woman possessed to get an honest, independent diagnostic review, I would have subjected my body to roughly 1,800 more daily injections of glatiramer acetate. Those needles would have drained about 1.5 million rubles from the public purse—not a single kopeck out of my pocket, because your taxes would have footed the bill. I refuse to even visualize what 1,800 more hardened, subcutaneous lumps would have done to my skin.
What truly terrifies me is that this system isn't correcting itself; it's scaling up. In 2017, the grand architect of MS diagnostics, McDonald, updated the criteria to state that an absence of active CNS inflammation is no longer a valid reason to strip away an established diagnosis. Ironically, that specific metric was a huge factor in clearing my name. They are now handing out MS tags faster and easier than ever, treating the diagnosis like a default label. No wonder the global patient population is exploding—I read a report recently claiming the numbers have tripled over the last thirty years.
It turns out, if you think about it, that they are treating increasingly more healthy people like me for sclerosis, and therefore their medicines show increasingly better results. My doctors told me that I, roughly speaking, should be grateful only to interferons and copaxones for the fact that I wasn't in a wheelchair yet, and I believed them. Believed them for 8 years! They were serious doctors, after all, the best specialists in the country; young ones study from their textbooks! To be honest, it’s better not to think about all of this extra times—it makes you terribly disgusted, and the conclusions in my head right now are such that my hand doesn't turn to type them, and the publishing house won't allow it. Perhaps I will keep my emotions to myself, and as a conclusion, I’d better write this, and I will even ask to highlight it in bold: burning lesions on an MRI are not always multiple sclerosis..
Marina's VK page is vk.com, email is solov2008@bk.ru. If you have any doubts that what is written above really happened, please contact Marina.
Chapter 1. Blood, Lymphocytes, and Multiple Sclerosis
«The blood is the life»
Bram Stoker, Dracula
Blood
An adult human carries about 5 liters of blood, and those 5 liters pack roughly 25 trillion cells. Try to visualize that number—it’s 25 thousand billion. Yet, because liquid plasma makes up 55% of your blood, all 25 trillion cells could fit inside a legendary 2.25-liter bottle of "Ochakovo" beer. If you filled that same bottle with the finest sand from the Maldives, it would hold about 220 to 230 million white grains. This means a single red blood cell—the most common cell in your body—is about 100,000 times smaller in volume than a grain of Maldivian sand.
In classical hematology, blood cells are split into three core categories: erythrocytes, platelets, and leukocytes. Erythrocytes haul oxygen across the body; platelets (which aren’t actually cells but "post-cellular structures") manage clotting; and leukocytes form the baseline of our immune system. This classification system evolved piece by step as new blood cells were discovered, finally freezing into its current form toward the late 19th century.
Every single blood cell is the byproduct of differentiation—essentially, a transformation—stemming from the exact same root: the hematopoietic stem cell. Living inside the bone marrow, the hematopoietic stem cell (HSC) is the absolute progenitor of all blood cells without exception. The total number of HSCs residing in human bone marrow is estimated between 100,000 and 1,000,000, and these cells outlive the humans they inhabit. While calculating this precisely is impossible, mouse experiments suggest that a "true, long-lived HSC" could easily survive for 400 to 500 years. But its defining superpower is asymmetric division—it gives birth to a brand-new cell while remaining completely unchanged itself.
The choice of which developmental path to take happens right inside the bone marrow. At the first stage of asymmetric division, the HSC buds off a "multipotent progenitor cell" while keeping its original form intact. Depending on the surrounding chemical signals, this multipotent progenitor turns into either a myeloid or a lymphoid cell line—which serves as the main alternative to classical blood classification. Myeloid cells (or rather, their progenitors) stay in the bone marrow to mature, while some lymphoid progenitors pack up and move to the thymus to undergo rigorous training. Part of the myeloid line turns into erythrocytes, others into platelets, and others into myeloid leukocytes. As for the lymphoid progenitors, they all become lymphocytes: either NK cells (Natural Killers), or T- and B-lymphocytes. The lymphocytes that mature inside the bone marrow become B-cells, while those trained in the thymus become T-cells.
Natural Killers are the shock troops of innate immunity, usually making up 5 to 10% of all lymphocytes. Like overzealous traffic cops, they constantly audit the Major Histocompatibility Complex (MHC) molecule—the genetic passport proving a cell is healthy and actually belongs to your body. If a virus or cancer forces a cell to hide this passport, the NK cell executes it on the spot, reacting to universal signals of cellular stress. The body relies on Natural Killers to purge cancerous, infected, and worn-out cells. Furthermore, because of their obsessive urge to "check ID," they contribute heavily to organ transplant rejection—which is why transplant surgeons absolutely detest them.
T- and B-lymphocytes, on the other hand, form the backbone of the adaptive immune system. On one hand, the architecture of this system shields us from virtually any virus or bacteria on earth. On the other, this exact design means that when things go sideways, lymphocytes can lose their minds and start tearing the body’s own tissues apart.
Lymphocytes and Their Receptors
So, lymphocytes mature in either the bone marrow or the thymus: the former become B-cells, the latter T-cells. Once they graduate from "school," they disperse to other organs of the immune system, but the defining choice of their life path happens right at the source. This is where lymphocyte receptors are built—and the blueprint of these receptors holds the root cause of all autoimmune diseases. Here is an absolutely counterintuitive, borderline bizarre fact: lymphocyte receptors are different. "Different" doesn't even do it justice: the human body can harbor one hundred million distinct T-lymphocyte receptors and one billion unique B-lymphocyte receptors.
Despite having less receptor diversity, T-cells outnumber B-cells in the body three to one. Many popular science texts frame T-lymphocytes as commanders and B-cells as raw privates, but frankly, that has nothing to do with reality. There is indeed a subset of T-lymphocytes that act as commanders, but that applies strictly to T-helpers—also known as CD4+ cells. If I were mapping out the military hierarchy of immunity, I would place B-lymphocytes right below them, since they rarely engage in hand-to-hand combat with pathogens. Only below them would I place T-killers (the frontline soldiers, CD8+) and T-regulatory cells (the military police). Why on earth do lymphocytes need so many receptor variants? The answer is simultaneously simple and complex: evolution is blind and incapable of thought. It ran prototypes of various immune systems, and the jackpot went to the one capable of defending the organism against literally anything.
The tip of a lymphocyte receptor is essentially a randomized sequence of amino acids. When a cell collides with a foreign fragment (an epitope) that fits this sequence, it triggers primary activation and readies itself for war—a war against anything matching that specific amino acid sequence. The process of randomly assembling a receptor is scientifically termed V(D)J recombination, where V stands for variable, D for diversity, and J for joining. Think of it as a modular construction set—some chains require V-D-J components, while others only need V-J, which is why the "D" sits in parentheses. To make things more chaotic, the splicing isn't always surgically precise, which jacks up the diversity of the finished receptors even further.
Why did evolution choose such a bizarre method to protect the body? First and foremost, because viruses evolve and constantly reshape their protein structures. If receptors were hardcoded to recognize a virus as a whole, a single mutation would instantly render it invisible, completely disarming the immune system. The evolutionary race was won by a blueprint that is brilliant in its simplicity: lymphocytes are prepped to destroy absolutely anything, but before they are deployed, they must pass a background check to ensure they won't attack the body's own cells. Science calls this pre-launch audit "central tolerance." If a newly assembled receptor reacts aggressively to the body's own tissues, the lymphocyte fails inspection and is ordered to commit cellular suicide. The scale of this purge is mind-boggling: no more than 5% of T-lymphocytes successfully graduate from the thymus.